About
Vaccines
Areas of Focus
Categories
VaccineNJ, NY, PA
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
2
As Collaborator
3
Total Enrollment
403
By Phase
PHASE1: 5
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04199169Lead Sponsor
Safety and Immunogenicity of a Nipah Virus Vaccine
PHASE1Completed
192 participants
Started: Feb 18, 2020 · Completed: May 6, 2022
NCT02718469Lead Sponsor
Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults
PHASE1Completed
38 participants
Started: Dec 22, 2015 · Completed: Sep 15, 2016
NCT02756208Collaborator
A Safety and Immunogenicity Trial of IHV01
PHASE1Completed
65 participants
Started: Nov 30, 2015 · Completed: Jul 31, 2018
NCT01859325Collaborator
Therapeutic Vaccine for HIV
PHASE1Completed
33 participants
Started: May 10, 2013 · Completed: Feb 26, 2017
NCT01496989Collaborator
Safety and Immunogenicity Study of HIV-MAG Vaccine +/- IL-12 and Ad35-GRIN/ENV in HIV-uninfected Volunteers
PHASE1Completed
75 participants
Started: Dec 31, 2011
Locations (1)
Headquarters
Pearl River, NY, United States
Map
Loading map...